DIM FR0013154002

Report

Real-time Euronext Paris - 01/21 11:35:25 am
377	EUR		-1.69%

01/05	SARTORIUS STEDIM BIOTECH : Half-year H2 2021 liquidity contract statement for Sartorius Stedim Biotech	PU
01/05	SARTORIUS STEDIM BIOTECH SA : Half-year liquidity contract statement for Sartorius Stedim Biotech	EQ
2021	SARTORIUS STEDIM BIOTECH : Monthly statement on outstanding equity shares and voting rights	CO

Summary

Quotes 5-day view Real-time Quote.

Real-time Euronext Paris

01/17/2022	01/18/2022	01/19/2022	01/20/2022	01/21/2022	Date
376.5(c)	364.1(c)	374.3(c)	383.5(c)	377(c)	Last
62 887	66 736	69 309	57 759	56 706	Volume
+2.59%	-3.29%	+2.80%	+2.46%	-1.69%	Change

More quotes

Estimated financial data (e)

Sales 2021	2 874 M 3 259 M 3 259 M
Net income 2021	595 M 675 M 675 M
Net Debt 2021	538 M 610 M 610 M
P/E ratio 2021	59,1x
Yield 2021	0,37%

Sales 2022	3 334 M 3 781 M 3 781 M
Net income 2022	696 M 789 M 789 M
Net Debt 2022	284 M 322 M 322 M
P/E ratio 2022	50,6x
Yield 2022	0,46%

Capitalization	34 752 M 39 415 M 39 409 M
EV / Sales 2021	12,3x
EV / Sales 2022	10,5x
Nbr of Employees	9 619
Free-Float	-

More Financials

Company

Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Companyâ€™s customers are...

Sector

Medical Equipment, Supplies & Distribution

Calendar

01/27 | 01:00am

Earnings Release

More about the company

Ratings of Sartorius Stedim Biotech

Trading Rating :

Investor Rating :

ESG Refinitiv :

More Ratings

All news about SARTORIUS STEDIM BIOTECH

01/05	SARTORIUS STEDIM BIOTECH : Half-year H2 2021 liquidity contract statement for Sartorius St..	PU
01/05	SARTORIUS STEDIM BIOTECH SA : Half-year liquidity contract statement for Sartorius Stedim ..	EQ
2021	SARTORIUS STEDIM BIOTECH : Monthly statement on outstanding equity shares and voting right..	CO
2021	Sartorius Acquires Majority Stake in ALS Automated Lab Solutions	DJ
2021	SARTORIUS STEDIM BIOTECH : strengthens its bioanalytics portfolio by acquiring a...	PU
2021	Sartorius To Buy 63% Interest In Germany's ALS Automated Lab Solutions	MT
2021	Sartorius to Pay $11.3 Million COVID-19 Bonus to Employees	MT
2021	SARTORIUS STEDIM BIOTECH : Monthly statement on outstanding equity shares and voting right..	CO
2021	Jiangsu Nhwa Pharma Signs Nearly $18 Million Deal to License Lundbeck's Schizophrenia D..	MT
2021	Sartorius to Invest EUR100 Million in France by 2025, Create Up to 400 Jobs	DJ
2021	SARTORIUS STEDIM BIOTECH : grows operations in France and is investing 100 million...	PU
2021	Sartorius to Invest Around EUR270 Million in South Korea Expansion	DJ
2021	SARTORIUS STEDIM BIOTECH : significantly expands activities in South Korea	PU
2021	CHA BIOTECH : Unit Signs Contract with Sartorius for Viral Vectors Process Technology	MT
2021	GLOBAL MARKETS LIVE : Kering, Netflix, Roche, United Airlines, Xiaomi...

More news

News in other languages on SARTORIUS STEDIM BIOTECH

01/20	AKTIEN FRANKFURT SCHLUSS : Erholung im Technologiesektor gibt Auftrieb
01/20	XETRA-SCHLUSS/DAX zeigt Stärke und Puma Ausdauer
01/20	AKTIEN FRANKFURT : Dax stabilisiert sich weiter
01/20	AKTIEN FRANKFURT : Dax bleibt mit leichten Verlusten auf Richtungssuche
01/19	AKTIEN FRANKFURT SCHLUSS : Nicht wirklich erholt

More news

Analyst Recommendations on SARTORIUS STEDIM BIOTECH

2021	ANALYST RECOMMENDATIONS : Acceleron Pharma, General Mills, Southwest Airlines, Home Depot,..
2021	SARTORIUS STEDIM BIOTECH : Gets a Buy rating from JP Morgan	MD
2019	GLOBAL MARKETS LIVE : T-Mobile, Sprint, Boeing, AB InBev…

More recommendations

Stock Trading Strategies

	SARTORIUS STEDIM BIOTECH - 2021
Technically solid

BUY

More Stock Trading Analysis

Provided by Scoopnest.com

Analysis

Video: This week's gainers and losers